524715:BOM
Sun Pharmaceutical Industries Ltd
1 760,00 ₹
arrow_downward
-0,03%(-0,60) 1K
16-okt, 15:30:00 (GMT+5:30) · INR
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_auto524715 tikeri uchun statistika yaratilmoqda...
Ochish
1 759,60 ₹
Yuqori
1 764,40 ₹
Past
1 744,85 ₹
Bozor kapitali
4,22Â trln
Oʻrtacha hajm
97,37Â ming
Hajmi
35,68Â ming
Dividend
0,91%
Choraklik dividendlar
4,00 ₹
Eks-dividend sanasi
7-iyl, 2026
P/E koeffitsiyenti
34,89
52 haftalik eng yuqori
2 047,55 ₹
52 haftalik eng past
1 583,60 ₹
Aksiya boʻyicha daromad
50,44 ₹
Muomaladagi aksiyalar
0,00
Xodimlar soni
47Â ming
Ochish
1 759,60 ₹
Yuqori
1 764,40 ₹
Past
1 744,85 ₹
Bozor kapitali
4,22Â trln
Oʻrtacha hajm
97,37Â ming
Hajmi
35,68Â ming
Dividend
0,91%
Choraklik dividendlar
4,00 ₹
Eks-dividend sanasi
7-iyl, 2026
P/E koeffitsiyenti
34,89
52 haftalik eng yuqori
2 047,55 ₹
52 haftalik eng past
1 583,60 ₹
Aksiya boʻyicha daromad
50,44 ₹
Muomaladagi aksiyalar
0,00
Xodimlar soni
47Â ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
ad-hoc-news.de
·
1 kun oldin
Sun Pharma stock: Results are due October 29 for Sun Pharma stock
ad-hoc-news.de
·
2 kun oldin
Analyst consensus puts Sun Pharma stock at INR 2,180.00
Profil
Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. It manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients in more than 100 countries. It is the largest pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company in the world.
Around 70% of Sun Pharma’s revenue is generated from international markets. The US and India are the largest markets, accounting for over 60% of the company's turnover. Manufacturing is across 43 locations in India, the US, Asia, Africa, Australia and Europe. The products cater to therapeutic segments covering psychiatry, anti-infectives, neurology, cardiology, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynaecology, respiratory, oncology, dental and nutritionals. Its active pharmaceutical products include baricitinib, brivaracetam, and dapaglifozin. Wikipedia
Sun Pharmaceutical Industries Ltd haqida
CEO-
Xodimlar soni47Â ming
Asos solingan1983
Bosh ofislarGoregaon East, Mumbay, Hindiston
Sektor-
Veb-saytsunpharma.com